HomeFDMT • NASDAQ
add
4D Molecular Therapeutics Inc
Previous close
$7.07
Day range
$6.65 - $7.07
Year range
$2.24 - $17.41
Market cap
318.04M USD
Avg Volume
1.94M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 15.00K | 200.00% |
Operating expense | 11.52M | 8.67% |
Net income | -54.66M | -56.38% |
Net profit margin | -364.39K | 47.87% |
Earnings per share | -0.98 | -55.56% |
EBITDA | -58.29M | -41.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 293.22M | -45.89% |
Total assets | 473.64M | -23.62% |
Total liabilities | 52.75M | 65.99% |
Total equity | 420.89M | — |
Shares outstanding | 46.70M | — |
Price to book | 0.78 | — |
Return on assets | -30.05% | — |
Return on capital | -31.71% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -54.66M | -56.38% |
Cash from operations | -43.38M | -43.43% |
Cash from investing | -13.85M | 81.16% |
Cash from financing | 862.00K | -95.00% |
Net change in cash | -56.37M | 34.86% |
Free cash flow | -21.58M | -25.31% |
About
Founded
2013
Headquarters
Website
Employees
227
